论文部分内容阅读
目的探讨舒血宁联合高压氧治疗急性脑梗死的临床疗效。方法将临床确诊的急性脑梗死的123例患者随机分为治疗组和对照组,对照1组用舒血宁+常规治疗;对照2组用高压氧+常规治疗;治疗组用上述两种方法同时治疗,观察疗效。结果治疗组总有效率92.9%,对照1组总有效率80.5%,对照2组总有效率77.5%,治疗组疗效明显优于对照组(P<0.05),且血液流变学较对照组明显改善。结论舒血宁联合高压氧治疗脑梗死不仅疗效显著,而且达到互补、协同、更安全的作用。
Objective To investigate the clinical effect of Shuxuening combined with hyperbaric oxygen on acute cerebral infarction. Methods 123 patients with clinically diagnosed acute cerebral infarction were randomly divided into treatment group and control group, control group 1 with Shuxuening + conventional treatment; control group 2 with hyperbaric oxygen + conventional treatment; treatment group with the above two methods simultaneously Treatment, observe the effect. Results The total effective rate was 92.9% in the treatment group, 80.5% in the control group 1 and 77.5% in the control group 2, and the curative effect in the treatment group was significantly better than that in the control group (P <0.05). The hemorrheology was significantly higher than that in the control group improve. Conclusion Shuxuening combined with hyperbaric oxygen treatment of cerebral infarction not only significant effect, but also to achieve complementary, synergistic and safer.